Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_assertion wasGeneratedBy ECO_0000203 NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_assertion wasDerivedFrom befree-2016 NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_assertion SIO_000772 24011934 NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_assertion evidence source_evidence_literature NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.
- NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_assertion description "[These studies identify dual targeted inhibitors of PI3K/mTOR in combination with inhibitors of RAS/ERK signalling as a potentially effective new approach to treating ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1108219.RAhZrLsmKFYny4BzYqH2l9qM3zl3w1VTvP_yCq1xIPpzw130_provenance.